Loading viewer...
conference
Format: PDF conference
Nektar Therapeutics presents its biopharmaceutical pipeline and growth strategy at the 2017 JP Morgan Healthcare Conference. The presentation outlines proprietary drug candidates including NKTR-181, NKTR-214, NKTR-358, and NKTR-262, with projected annual revenue of $375-450M by 2021, supported by integrated R&D and manufacturing capabilities.
other
91 Pages
conference
19 Pages
5G Americas
CapitaLand Investment 2024 Singapore SGX-DBS Conference Presentation
conferenceconference
47 Pages
CapitaLand Investment Limited
Iridium Communications 2024 Investor Conference Presentation
conferenceconference
18 Pages
Iridium Communications Inc.